RudaCure is a biotechnology company founded in 2018 that is developing treatments for incurable diseases with high unmet needs.
Currently focusing on the development of two main assets (RCI001 & RCI002), with RCI001 being a treatment for Dry Eye Disease and RCI002 being a treatment for various pain diseases.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 1001, 145, Gasan Digital 1-Ro, Geumcheon-Gu, Seoul,korea, Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.rudacure.com/
- HQ
- Seoul
Rudacure Questions
Rudacure's website is http://www.rudacure.com/
Rudacure's LinkedIn profile is https://kr.linkedin.com/company/rudacure
Rudacure has
14 employees.
View email and phone details for 14
employees at Rudacure.
Rudacure's industry is
Pharmaceutical Manufacturing
Rudacure's top competitors are
5one8 Ab,
C&r Research, Inc,
The Whole Journey,
Microbiotix Co., Ltd.,
Boost!,
Goojung Ent Co., Ltd.,
株式会社fdalco,
Pilipala: Thyroid Health Tracker,
Oysterable Co., Ltd.,
Bitmoves Japan Inc..
Rudacure's categories are Pharmaceutical Manufacturing
Rudacure's founding year is 2018
